Treating Phobia by a New Emotional Regulation Method (Tipi)

NCT ID: NCT04165954

Last Updated: 2019-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

170 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-01-01

Study Completion Date

2006-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Background In emotional regulation, the patient remembers an emotional situation, focuses his attention on his physical sensations when he relives a recent emotion, and let evolve his sensations.
* Method Evaluate the relevance of this method by an interventional study, in a pre-post mono group, on patients suffering from phobia.
* Objective The investigators aim to validate the effectiveness of this emotional regulation method and compare its results with that of conventional methods. Sessions are individual and repeated until the disappearance of phobic fear.

The present study may contribute to propose a new possibility to treat phobias in a simple and fast way.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Between 2003 and 2006, the investigators conducted an exploratory, prospective and comparative research study, taking each person as their own control, to evaluate the benefits of the type of emotional regulation developed by the Tipi association on a population suffering from phobias.

\- Participants Phobias can be categorized by type, as defined in the DSM IV, the standard reference during the study period (American Psychiatriy Association, 2000) : agoraphobias, social phobias, specific situational phobias (claustrophobia, transport phobia), phobias linked to the natural environment (heights, water, fire), to animals (spiders, snakes, amphibians, tentacled shellfish) and other types of specific phobias (fear of physical contact, being dirtied, contaminated, vomiting), phobia of blood - injections - medical techniques - accidents.

The investigators aim to conduct a prior and systematic verification with each person to confirm that their fears were phobias as defined in the DSM IV (American Psychiatriy Association, 2000). The phobia must be diagnosed by a doctor or psychiatrist. Each people must provide a medical certificate that evidenced the diagnosis in writing.

All people must read an information form on "Understanding your emotions" All participants must have suffered from their phobias for a long time. They have to describe their treatment.

Everybody in the study population have to provide a short-written report on the effects of the session(s) 1 week, 1 month, 3 months and 12 months after the session.

* Intervention (see below)
* Follow-up During the one-year follow-up period, the patient was requested to send a written self-assessment of his situation and the change and/or disappearance of his phobia. If the investigators didn't receive the person's assessment, the investigators followed-up with a mail and a phone call.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phobic Fear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult: 18-90 years old
* Adult People with phobic fear in the DSM IV classification
* Phobic people: agoraphobia, with or without panic associated, social phobias and specific phobias. Diagnosis of phobias must be established by the medical world during consultations and explorations. This is systematically checked with the patient to see if the fears come under a phobia as defined in the DSM IV, reference at the time in 2006 (ref DSM IV). The list of phobias classified by type is as follows: animal type or insects; natural environment type (phobias storms, height, water ...); blood type - injection - accident (phobia of seeing blood or an accident or having an injection or any other invasive medical procedure); situational type (fear of specific situations such as public transport, tunnels, bridges, elevators, air travel, driving a car or enclosed areas); another type: afraid to choke, to vomit or contract an illness, fear of falling, and fears about loud noises or disguised characters.
* People accepting regular follow-up until one year after the first session.

Exclusion Criteria

Subject unable to read or/and write
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Luc Nicon, Education Specialist, Founder of "Tipi", a non-profit French association

UNKNOWN

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Luc Nicon

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Montpellier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Uhmontpellier

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECHMPL19_0539

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mechanisms of Panic Disorders Treatment
NCT01323556 UNKNOWN PHASE2/PHASE3
Treatment for Specific Phobias in Children
NCT00051220 COMPLETED PHASE1/PHASE2